EHR-based marker flags transplant patients at risk of organ rejection

Researchers from Mount Sinai Health System and Texas Children's Hospital have developed an EHR-based marker to spot transplant patients likely to reject their organs due to medication nonadherence. The Medication Level Variability Index, evaluated in a multicenter trial, provides an objective measure to predict rejection risk. This breakthrough is crucial as it could significantly improve patient outcomes by enabling timely interventions to enhance medication adherence. This development underscores the potential of electronic health records to transform transplant care and reduce rejection rates.